EC
VINC

EcoR1 Capital’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

EcoR1 Capital’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,025
Closed -$10M – 79
2020
Q4 		$10M Sell
24,025
-7,500
-24% -$2.36M 0.54% 28
2020
Q3 		$7.82M Buy
+31,525
New +$6.41M 0.56% 26

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

EcoR1 Capital's VINC Position: Q1 2021 in Review

EcoR1 Capital sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2021, closing a stake of 24,025 shares — an estimated $10M sold.

EcoR1 Capital first reported a position in VINC in Q3 2020 and held it in 2 quarters. The position peaked at $10M in Q4 2020. 36 funds tracked by Wall St. Rank hold VINC as of Q1 2021.

  • EcoR1 Capital reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • EcoR1 Capital sold 24,025 Vincerx Pharma, Inc. Common Stock shares in Q1 2021, an estimated $10M.
  • EcoR1 Capital first reported a position in Vincerx Pharma, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • EcoR1 Capital's Vincerx Pharma, Inc. Common Stock position peaked at $10M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2021.

Based on EcoR1 Capital's 13F filing for Q1 2021, filed 17 May 2021.